For those who require treatment, the current first-line bisphosphonate, due to its potency and prolonged duration of action, is zoledronate (zoledronic acid). It is the bisphosphonate most likely to relieve pain from active Paget’s disease. It is usually given in a hospital, as an outpatient.
A single dose of 5mg is given through an infusion (a drip) directly into the bloodstream (intravenous), over 15 minutes.
Over the following months, this treatment often normalises the abnormal bone remodelling and one dose can be effective for many years.
Booklets containing more detailed information are available to download in the Members' Area of this website. Alternatively, they can be posted to you. Please telephone 0161 799 4646 or use the contact form.
Details regarding membership and its benefits can be found by following this link.